A comparison of strategies for switching patients from amitriptyline to duloxetine for the management of diabetic peripheral neuropathic pain

Trial Profile

A comparison of strategies for switching patients from amitriptyline to duloxetine for the management of diabetic peripheral neuropathic pain

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 May 2008

At a glance

  • Drugs Amitriptyline; Duloxetine
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Adverse reactions
  • Sponsors Eli Lilly
  • Most Recent Events

    • 02 Aug 2007 Status changed from in progress to completed.
    • 24 Jul 2007 The expected completion date for this trial is now 1 Nov 2008.
    • 27 Jan 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top